Cytena
About Cytena
Cytena is a company founded in 2014 was acquired by CELLINK in August 2019.. Cytena has raised $4.59 million across 2 funding rounds from investors including CELLINK and High-Tech Gründerfonds. Cytena offers products and services including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS. Cytena operates in a competitive market with competitors including NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others.
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Cytena Gmbh
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cytena
Cytena offers a comprehensive portfolio of products and services, including UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Optimizes monoclonality proof and cell tracking in research.
Enables rapid dispensing of fluorescent cells for assays.
Facilitates powerful dispensing of unlabeled cells in workflows.
Automates washing and dispensing for reproducible lab processes.
Unlock access to complete
Unlock access to complete
Funding Insights of Cytena
Cytena has successfully raised a total of $4.59M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $3.39 million completed in March 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $3.4M
-
First Round
First Round
(28 Apr 2015)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2019 | Amount | Series A - Cytena | Valuation | HTGF |
|
| Apr, 2015 | Amount | Seed - Cytena | Valuation | HTGF |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cytena
Cytena has secured backing from 2 investors, including venture fund investors. Prominent investors backing the company include CELLINK and High-Tech Gründerfonds. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage investments are made in high-tech startups by HTGF.
|
Founded Year | Domain | Location | |
|
3D bioprinters and bioinks are developed for research applications.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cytena
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cytena
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cytena Comparisons
Competitors of Cytena
Cytena operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NanoCellect Biomedical, ThinkCyte, Singulex, Cell Microsystems and Silicon Biosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Develops flow cytometry and cell sorting technology
|
|
| domain | founded_year | HQ Location |
Cell analysis and sorting technologies are developed with AI integration.
|
|
| domain | founded_year | HQ Location |
Single-molecule counting technology is developed for cardiovascular biomarker detection.
|
|
| domain | founded_year | HQ Location |
Developer of a technology to isolate and recover single cells for molecular analysis
|
|
| domain | founded_year | HQ Location |
Lab-on-a-chip technologies for miniaturized cell-biology testing are developed.
|
|
| domain | founded_year | HQ Location |
Cell and molecular-based diagnostics for cancer management are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Cytena
Frequently Asked Questions about Cytena
When was Cytena founded?
Cytena was founded in 2014 and raised its 1st funding round 1 year after it was founded.
Is Cytena a funded company?
Cytena is a funded company, having raised a total of $4.59M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.2M, raised on Apr 28, 2015.
What does Cytena do?
Founded in 2014, Cytena operates in the biotechnology sector focused on cell analysis tools. The cy-Clone device is utilized for separating individual cells, supporting biological drug development and genetic studies in cancer and stem cell research. An automated imaging system is integrated to encapsulate cells within droplets, enabling delivery to diverse substrates for further applications.
Who are the top competitors of Cytena?
Cytena's top competitors include NanoCellect Biomedical, ThinkCyte and Silicon Biosystems.
What products or services does Cytena offer?
Cytena offers UP.SIGHT™ 2nd Gen, F.SIGHT™ 2.0, C.SIGHT™ 2.0, and C.WASH™ PLUS.
Who are Cytena's investors?
Cytena has 2 investors. Key investors include CELLINK, and High-Tech Gründerfonds.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.